Benjamin F. Edwards & Company, Inc. Sangamo Therapeutics, Inc Call Options Transaction History

Benjamin F. Edwards & Company, Inc.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 02, 2021	BUY	$9.01 - $12.01 $5,406 - $7,206	600 Added 150.0%	1,000 $2,000
Q2 2021 Aug 11, 2021	SELL	$10.17 - $12.64 $14,238 - $17,696	-1,400 Reduced 77.78%	400 $2,000
Q1 2021 May 14, 2021	BUY	$10.88 - $17.05 $10,880 - $17,050	1,000 Added 125.0%	1,800 $2,000
Q4 2020 Feb 16, 2021	BUY	$9.23 - $18.18 $7,384 - $14,544	800 New	800 $5,000

115

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $304M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.